Related Experiment Video
Updated: May 12, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
MicroRNA-323-3p: a new biomarker and potential therapeutic target for rheumatoid arthritis
Tao Xu1, Cheng Huang, Zhaolin Chen
1School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Mei Shan Road, Hefei, 230032, Anhui Province, China.
Abstract:
Increased expression of microRNA-323-3p (miR-323-3p) has been demonstrated in rheumatoid arthritis synovial fibroblast. The gene encoding miR-323-3p, which is a biomarker in immune and inflammatory responses, occurs in an miRNA cluster in chromosomal region 14q32.31.
Insights
Increased microRNA-323-3p (miR-323-3p) expression is linked to rheumatoid arthritis synovial fibroblasts. This microRNA plays a role in immune and inflammatory responses, with its gene located at chromosomal region 14q32.31.
Area of Science:
- Molecular biology
- Immunology
- Genetics
Background:
- Rheumatoid arthritis (RA) is characterized by synovial fibroblast (SF) abnormalities.
- MicroRNAs (miRNAs) are key regulators of gene expression involved in immune and inflammatory processes.
Discussion:
- The study investigates the role of microRNA-323-3p (miR-323-3p) in the context of rheumatoid arthritis.
- Elevated miR-323-3p levels were observed in RA synovial fibroblasts, suggesting its potential involvement in disease pathogenesis.
Key Insights:
- miR-323-3p is upregulated in rheumatoid arthritis synovial fibroblasts.
- The gene encoding miR-323-3p is located in the 14q32.31 chromosomal region.
- miR-323-3p functions as a biomarker in immune and inflammatory responses.
Outlook:
- Further research is warranted to elucidate the precise mechanisms by which miR-323-3p contributes to RA.
- Targeting miR-323-3p could represent a novel therapeutic strategy for rheumatoid arthritis.
Related Concept Videos
MicroRNAs
MicroRNAs